Volociximab

Volociximab Suppliers list
Company Name: NCE Biomedical Co.,Ltd.  
Tel: 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Email:
Products Intro: Product Name:VolocixiMab
CAS:558480-40-3
Purity:99% HPLC Package:50Mg,100Mg,500Mg,1g,5g,10g,50g,100g,500g,1kg Remarks:XYA1201
Company Name: SPIRO PHARMA  
Tel:
Email: eric_feng1954@126.com
Products Intro: Product Name:VolocixiMab
CAS:558480-40-3
Purity:95% -98%HPLC Package:1GR;10GR;50GR;100GR;250GR;500GR;1KG;5KG;10KG;100KG
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 021-61312847; 18021002903
Email: 3008007409@qq.com
Products Intro: Product Name:Volociximab
CAS:558480-40-3
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:100μg Remarks:K13726
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Volociximab
CAS:558480-40-3
Purity:95% Package:100ug;500ug;1mg
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Products Intro: Product Name:Volociximab
CAS:558480-40-3
Purity:95% Package:1mg;1g;100g
Volociximab Basic information
Product Name:Volociximab
Synonyms:Volociximab;Research Grade Volociximab (DHC35101);Research Grade Volociximab
CAS:558480-40-3
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Volociximab Structure
Volociximab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Volociximab Usage And Synthesis
UsesAntiangiogenic agent to treat solid tumors and age-related macular degeneration.
in vivo

Volociximab (300 μg/eye; intravitreal injection; once weekly for 4 weeks) has well tolerance and inhibits angiogenesis in laser induced choroidal neovascularization (CNV) of cynomolgus monkey model[1].
Volociximab (10 mg/kg; i.v.; twice weekly for 3 weeks) suppresses tumor progress in rabbits VX2 model[2].

IC 50α5β1: 0.2 nM (EC50)
Volociximab Preparation Products And Raw materials
Tag:Volociximab(558480-40-3) Related Product Information
Anetumab Ravtansine Alemtuzumab Atibuclimab Gantenerumab Glembatumumab Ponezumab Olaratumab Pertuzumab Tildrakizumab Manelimab

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.